WAY-629
Izvor: Wikipedija
| WAY-629 | |||
|---|---|---|---|
| |||
| IUPAC ime |
| ||
| Identifikacija | |||
| ChEMBL[1] | CHEMBL258465 | ||
| Jmol-3D slike | Slika 1 | ||
| |||
| Svojstva | |||
| Molekulska formula | C15H18N2 | ||
| Molarna masa | 226,32 g mol-1 | ||
|
| |||
| Infobox references | |||
WAY-629 je 5-HT2C agonist za koji je putem eksperimenata na pacovima utvrđeno da umanjuje apetitit. On je korišten kao početna tačka za razvoj potentnih i selektivnih 5-HT2C agonista za tretman gojaznosti.[2]
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.
- ↑ Sabb, AL (May 2004). „Cycloalkyl[b][1,4]benzodiazepinoindoles are agonists at the human 5-HT2C receptor”. Bioorganic and Medicinal Chemistry Letters 14 (10): 2603–7. PMID 15109661.
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.
Cover photo is available under {{::mainImage.info.license.name || 'Unknown'}} license.
Cover photo is available under {{::mainImage.info.license.name || 'Unknown'}} license.
Credit:
(see original file).
